Saxagliptin - PDFSEARCH.IO - Document Search Engine

Saxagliptin
Results: 87

#	Item
61	The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Anorectics Organochlorides Phenethylamines Sibutramine Center for Drug Evaluation and Research Abbott Laboratories Management of obesity Obesity Health Medicine Food and Drug Administration
62	The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Dermatologic and Ophthalmic Drugs Advisory Committee Center for Drug Evaluation and Research Ranibizumab Genentech Macular degeneration Macular edema Intravitreal administration Food and Drug Administration Medicine Pharmaceutical sciences
63	The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Clinical pharmacology Therapeutics United States Public Health Service New Drug Application Food and Drug Administration Pharmaceutical sciences Clinical research
64	The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus Add to Reading List Source URL: www.fda.gov Language: English Chemistry Medicine Pharmaceutical sciences GlaxoSmithKline Rosiglitazone Eli Lilly and Company Pioglitazone Steven Nissen Center for Drug Evaluation and Research Food and Drug Administration Pyridines Thiazolidinediones
65	The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus Add to Reading List Source URL: www.fda.gov Language: English Anorectics Combination drugs Food and Drug Administration Bupropion/naltrexone Bupropion New Drug Application Naltrexone Management of obesity Phentermine/topiramate Pharmacology Chemistry Medicine
66	The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus Add to Reading List Source URL: www.fda.gov Language: English Chemistry Medicine Pharmaceutical sciences GlaxoSmithKline Rosiglitazone Eli Lilly and Company Pioglitazone Steven Nissen Center for Drug Evaluation and Research Food and Drug Administration Pyridines Thiazolidinediones
67	The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus Add to Reading List Source URL: www.fda.gov Language: English Medicine Lorcaserin Center for Drug Evaluation and Research New Drug Application Food and Drug Administration Pharmaceutical sciences Pharmacology
68	The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Dermatologic and Ophthalmic Drugs Advisory Committee Center for Drug Evaluation and Research George Yancopoulos Regeneron Ketorolac Food and Drug Administration Pharmaceutical sciences Clinical research
69	The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus Add to Reading List Source URL: www.fda.gov Language: English Anorectics Food and Drug Administration Pharmaceutical industry Clinical research Phentermine/topiramate Phentermine Topiramate Management of obesity Center for Drug Evaluation and Research Pharmaceutical sciences Pharmacology Health
70	The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus Add to Reading List Source URL: www.fda.gov Language: English Clinical research Dermatologic and Ophthalmic Drugs Advisory Committee Genentech Ranibizumab Center for Drug Evaluation and Research Macular degeneration Macular edema Food and Drug Administration Pharmaceutical sciences Health

UPDATE